| View |
|
DR-XY45685
|
None
|
Hydrocortisone
|
10mg/g (1% w/w)
|
Topical Cream
|
Corticosteroid
|
M.C.B. Dermatological Products
|
Philippines
|
Renewal
|
26 January 2022
|
02 December 2026
|
| View |
|
DR-XY45687
|
Lenvatinib (as mesilate)
|
Lenvima
|
10mg
|
Capsule
|
Protein Kinase Inhibitor
|
Eisai Co., Ltd. (Kawashima Plant)
|
Japan
|
Monitored Release (Variation)
|
20 July 2023
|
10 December 2025
|
| View |
|
DR-XY45689
|
Folic Acid
|
Folitan
|
5 mg
|
Capsule
|
Vitamin
|
Interchemex Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 January 2022
|
06 December 2026
|
| View |
|
DR-XY45690
|
Ascorbic Acid (as Sodium Ascorbate)
|
ZERRUVIT-C
|
500mg
|
Capsule
|
Vitamin
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
Renewal
|
03 January 2022
|
08 December 2026
|
| View |
|
DR-XY45691
|
Ascorbic Acid
|
None
|
100mg/ 5mL
|
Syrup
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 March 2022
|
08 December 2026
|
| View |
|
DR-XY45693
|
Ascorbic acid (as Sodium Ascorbate)
|
None
|
500mg
|
Capsule
|
VITAMIN
|
Northfield Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
31 October 2021
|
08 December 2026
|
| View |
|
DR-XY45696
|
Bromhexine hydrochloride
|
Bisolvon
|
4 mg/5 mL
|
Syrup (Pediatric) (Strawberry-Cherry
Flavor)
|
Mucolytic
|
PT. Boehringer Ingelheim Indonesia
|
Indonesia
|
Initial [Variation)
|
01 June 2022
|
01 June 2027
|
| View |
|
DR-XY45699
|
Simvastatin
|
Lipivast
|
40mg
|
Film-Coated Tablet
|
Anti-hyperlipidemia (HMG-CoA Reductase Inhibitor)
|
Celogen Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
14 January 2022
|
13 December 2026
|
| View |
DR-XY45700_PI_01.pdf
|
DR-XY45700
|
Budesonide + Formoterol fumarate dihydrate
|
Symbicort Rapihaler
|
80 mcg/4.5 mcg per Actuation
|
Inhalation Aerosol
(Pressurized Suspension for Inhalation)
|
Adrenergics and Other Drugs for Obstructive Airway
Disease
|
AstraZeneca Dunkerque Production
|
France
|
Initial
|
28 March 2022
|
09 December 2026
|
| View |
DR-XY45701_PI_01.pdf
|
DR-XY45701
|
Budesonide + Formoterol fumarate dihydrate
|
Symbicort Rapihaler
|
160 mcg/4.5 mcg per Actuation
|
Inhalation Aerosol
(Pressurized Suspension for Inhalation)
|
-
|
AstraZeneca Dunkerque Production
|
France
|
-
|
28 March 2022
|
09 December 2026
|
| View |
|
DR-XY45702
|
Esmolol hydrochloride
|
Esmolife
|
10mg/ mL (100 mg/ 10 mL)
|
Solution for IV Injection
|
Beta Adrenoceptor Blocker
|
Baxter Pharmaceuticals India Private Limited
|
India
|
Automatic Renewal
|
24 September 2021
|
09 December 2026
|
| View |
|
DR-XY45704
|
Oxycodone hydrochloride
|
OxyContin Neo
|
10mg
|
Controlled-Release Tablet
|
Opioid Analgesic
|
Purdue Pharmaceuticals L.P.
|
U.S.A.
|
Automatic Renewal
|
19 January 2022
|
15 December 2026
|
| View |
|
DR-XY45706
|
Oxycodone hydrochloride
|
OxyContin Neo
|
20mg
|
Controlled-Release Tablet
|
Opioid Analgesic
|
Purdue Pharmaceuticals L.P.
|
U.S.A.
|
Automatic Renewal
|
10 January 2022
|
15 December 2026
|
| View |
|
DR-XY45708
|
Oxycodone hydrochloride
|
OxyContin Neo
|
40mg
|
Controlled-Release Tablet
|
Opioid Analgesic
|
Purdue Pharmaceuticals L.P.
|
U.S.A.
|
Automatic Renewal
|
26 October 2021
|
15 December 2026
|
| View |
|
DR-XY45710
|
Oxycodone hydrochloride
|
OxyContin Neo
|
80mg
|
Controlled-Release Tablet
|
Opioid Analgesic
|
Purdue Pharmaceuticals L.P.
|
U.S.A.
|
Automatic Renewal
|
23 September 2021
|
15 December 2026
|
| View |
|
DR-XY45713
|
Dexamethasone Sodium Phosphate
|
Cordex 5
|
5 mg/ 5 mL
|
Solution For Injection (IM/IV)
|
-
|
Jeil Pharmaceutical Co., Ltd.
|
Korea
|
-
|
08 February 2022
|
04 January 2027
|
| View |
|
DR-XY45714
|
Ceftolozane (as sulfate) + Tazobactam (as sodium)
|
Zerbaxa
|
1 g/500 mg
|
Powder for Injection (I.V. Infusion)
|
-
|
Steri-Pharma, LLC
|
United States of America
|
Initial (from Monitored Release)
|
16 February 2023
|
19 December 2026
|
| View |
|
DR-XY45715
|
Multivitamins and Minerals (Orange Flavor)
|
Berocca Performance
|
[see reverse]
|
Effervescent Tablet
|
Vitamins and Minerals
|
PT. Bayer Indonesia
|
Indonesia
|
Automatic Renewal
|
09 October 2021
|
16 December 2026
|
| View |
|
DR-XY45716
|
Phenylpropanolamine hydrochloride
Chlorphenamine Maleate + Paracetamol
|
Decolgen Forte
|
25 mg/ 2 mg/ 500 mg
|
Tablet
|
-
|
PT. Medifarma Laboratories, Inc.
|
Indonesia
|
-
|
02 February 2021
|
16 December 2026
|
| View |
|
DR-XY45717
|
Docetaxel
|
Daxotel
|
20 mg/mL
|
Concentrate Solution for IV Infusion
|
Antineoplastic
|
Fresenius Kabi Oncology Limited
|
India
|
Automatic Renewal
|
13 October 2021
|
16 December 2026
|